About Palomar Medical Technologies (NASDAQ:PMTI)
Palomar Medical Technologies, Inc. (Palomar) is a researcher and developer of aesthetic light-based systems for hair removal and other cosmetic procedures, including both lasers and high powered lamps. The Company offers a range of products based on technologies that include, but are not limited to: hair removal; body sculpting, including laser-assisted liposuction; removal of vascular lesions, such as rosacea, spider veins, port wine stains and hemangiomas; wrinkle reduction; removal of leg veins; removal of benign pigmented lesions, such as age and sun spots, freckles and melasma; tattoo removal; acne treatment; skin resurfacing, pseudofolliculitis barbae (PFB) treatment; treatment of red pigmentation in hypertrophic and keloid scars; treatment of verrucae, skin tags and seborrheic keratosis; skin tightening through soft tissue coagulation; scars, and other skin treatments. In June 2013, Cynosure Inc announced the completion of its acquisition of Palomar Medical Technologies Inc.
Industry, Sector and Symbol
Industry Medical Equipment, Supplies & Distribution
Sub-IndustryHealth Care Equipment
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Palomar Medical Technologies (NASDAQ:PMTI) Frequently Asked Questions
What is Palomar Medical Technologies' stock symbol?
Palomar Medical Technologies trades on the NASDAQ under the ticker symbol "PMTI."
Who are some of Palomar Medical Technologies' key competitors?
Some companies that are related to Palomar Medical Technologies include Transenterix (TRXC), Syneron Medical (ELOS), SurModics (SRDX), Utah Medical Products (UTMD), Antares Pharma (ATRS), Sientra (SIEN), CRH Medical (CRHM), T2 Biosystems (TTOO), Ocular Therapeutix (OCUL), SeaSpine (SPNE), Bioquell (BQE), Tandem Diabetes Care (TNDM), Surgical Innovations Group (SUN), Soleno Therapeutics (SLNO), Alliqua Biomedical (ALQA), Cytori Therapeutics (CYTX), NeuroMetrix (NURO) and Lombard Medical (EVARF).
Who are Palomar Medical Technologies' key executives?
Palomar Medical Technologies' management team includes the folowing people:
- Joseph P. Caruso, Chairman of the Board, President, Chief Executive Officer (Age 54)
- Paul S. Weiner, Chief Financial Officer, Treasurer (Age 53)
- Louis P. Valente, Director (Age 81)
- Jeanne Cohane, Independent Director (Age 65)
- Damian N. Dell'Anno, Independent Director
- Nicholas P. Economou Ph.D., Independent Director (Age 63)
- James G. Martin Ph.D., Independent Director (Age 78)
How do I buy Palomar Medical Technologies stock?
Shares of Palomar Medical Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Palomar Medical Technologies' stock price today?
One share of Palomar Medical Technologies stock can currently be purchased for approximately $13.41.
How big of a company is Palomar Medical Technologies?
Palomar Medical Technologies has a market capitalization of $267.90 million.
How can I contact Palomar Medical Technologies?
Palomar Medical Technologies' mailing address is 15 Network Drive, BURLINGTON, MA 1803, United States. The healthcare company can be reached via phone at +1-781-9932300.
MarketBeat Community Rating for Palomar Medical Technologies (PMTI)MarketBeat's community ratings are surveys of what our community members think about Palomar Medical Technologies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Palomar Medical Technologies (NASDAQ:PMTI) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Palomar Medical Technologies (NASDAQ:PMTI) Earnings History and Estimates Chart
Palomar Medical Technologies (NASDAQ PMTI) Earnings History by Quarter
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|5/2/2013||Q1 2013||($0.01)||($0.06)||$20.30 million||$23.20 million||View||N/A|
|2/7/2013||Q4 2012||$0.04||$0.12||$22.70 million||$23.40 million||View||N/A|
Palomar Medical Technologies (NASDAQ:PMTI) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Palomar Medical Technologies (NASDAQ:PMTI)
No dividend announcements for this company have been tracked by MarketBeat.com
Palomar Medical Technologies (NASDAQ PMTI) Insider Trading and Institutional Ownership History
Palomar Medical Technologies (NASDAQ PMTI) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|6/12/2013||A Neil Pappalardo||Director||Sell||15,000||$13.45||$201,750.00|| |
|6/11/2013||Joseph P Caruso||CEO||Sell||21,711||$13.42||$291,361.62|| |
|6/7/2013||Joseph P Caruso||CEO||Sell||2,056||$13.47||$27,694.32|| |
|5/28/2013||Joseph P Caruso||CEO||Sell||40,000||$13.60||$544,000.00|| |
|5/24/2013||Joseph P Caruso||CEO||Sell||19,028||$13.58||$258,400.24|| |
|5/24/2013||Paul S Weiner||CFO||Sell||78,338||$13.59||$1,064,613.42|| |
|5/22/2013||Joseph P Caruso||CEO||Sell||20,000||$13.58||$271,600.00|| |
|5/17/2013||Joseph P Caruso||CEO||Sell||22,900||$13.58||$310,982.00|| |
|5/15/2013||Joseph P Caruso||CEO||Sell||70,000||$13.58||$950,600.00|| |
|5/14/2013||Paul S Weiner||CFO||Sell||40,485||$13.60||$550,596.00|| |
|5/9/2013||James G Martin||Director||Sell||14,756||$13.52||$199,501.12|| |
|11/15/2012||Broadwood Partners Lp||Major Shareholder||Buy||13,118||$7.19||$94,318.42|| |
Palomar Medical Technologies (NASDAQ PMTI) News Headlines
Palomar Medical Technologies (NASDAQ:PMTI) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Palomar Medical Technologies (NASDAQ:PMTI) Income Statement, Balance Sheet and Cash Flow Statement
Palomar Medical Technologies (NASDAQ PMTI) Stock Chart for Thursday, December, 14, 2017